Medical Technical Options Committee Essential Use Nominations

Slides:

Advertisements

Similar presentations

T E A P a n d T O C s - A s s e s s m e n t , M O P - 20, D o h a 1 The TEAP and TOC 2010 Assessment Reports Timelines and issues that will be dealt.

Advertisements

1 M o n t r e a l P r o t o c o l M O P m e e t i n g, N o v e m b e r , B a n g k ok TEAP/MTOC Addendum Report Review of Revised Essential.

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, N o v , D o h a 1 TEAP Update Presentation for MOP-20.

Recommending a Strategy Ideas for Today and Tomorrow.

Title Presented by: For: Date:. Summary The summary is intended to provide the audience with a quick overview and basic understanding of the essential.

Update to RMS February 3,  2015 AMWG Leadership ◦ Esther Kent (CNP) and John Schatz (TXU), by affirmation, return as co-chairs  2015 AMWG Goals.

M o n t r e a l P r o t o c o l O E W G - 32, July 2012, Bangkok (Thailand) Response to Decision XXIII/5: Quarantine and Pre-shipment uses of Methyl.

Decisions of the Parties Related to Essential Use Nominations (EUNs) Ozone Secretariat 6 July 2008 Bangkok.

MBTOC Cochairs :  Mohammed Besri  Marta Pizano  Ian Porter Methyl Bromide CUE: Final Recommendations M o n t r e a l P r o t o c o l 26 th MOP,

TEAP Methyl Bromide Technical Options Committee TEAP Methyl Bromide Technical Options Committee 1 Montreal Protocol, MOP 25, Bangkok, October 2013.

Ministério da Saúde Secretaria de Vigilância em Saúde - SVS Coordenação Geral de Vigilância em Saúde Ambiental - CGVAM Bangkok - July 6 th, 2008 CONSULTATIVE.

Critical Use Nomination: Interim Recommendations MBTOC Cochairs :  Mohamed Besri  Michelle Marcotte  Marta Pizano  Ian Porter 31st OEWG - Montreal.

Critical Use Nomination: Interim Recommendations MBTOC Cochairs :  Mohamed Besri  Michelle Marcotte  Marta Pizano  Ian Porter Montreal Protocol, OEWG-32,

Preparing an Essential-Use Nomination for CFC MDIs: The U.S. Experience Consultative Meeting on Essential Use Nominations Bangkok, Thailand 6 July 2008.

Experiences and Lessons Learned from Essential Use Nominations in Developed Countries: Industry Perspectives Peter Blenkinsop on behalf of the International.

CFCs in inhalers for asthma and COPD What’s happening? © 2009 United Nations Environment Programme Developed in association with the National Asthma Council.

Phase Difference = Phase Difference = 0.05.

M o n t r e a l P r o t o c o l O E W G m e e t i n g, J u n e , G e n e v a 1 TEAP Progress Report.

1 IMPLEMENTATION OF MONTREAL PROTOCOL IN INDIA Ozone Cell Government of India Ministry of Environment and Forests.

Overview of the CFC MDI essential use process Prof Ashley Woodcock MD FRCP FMedSci University of Manchester.

Critical Use Nominations: Final Recommendations MBTOC Cochairs :  Mohamed Besri  Michelle Marcotte  Marta Pizano  Ian Porter 24th MOP - Geneva Montreal.

1 POLICIES AND REGULATORY FRAMEWORK FOR ODS PHASE-OUT OZONE CELL GOVERNMENT OF INDIA MINISTRY OF ENVIRONMENT & FORESTS.

TEAP CTOC Essential Use Nominations Report Final Evaluation M o n t r e a l P r o t o c o l M O P m e e t i n g, N o v e m b e r

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Technology and Economic Assessment Panel Progress Report 2012.

TEAP CTOC Essential Use Nomination Essential Use Nomination for Laboratory and Analytical Use of CTC - Background China requested 70 t of CTC for.

Prime Responsibility for Radiation Safety

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

N O T E “CLICK” TO CONTINUE… If the slide show is not launched, click on View  Slide Show in the menu bar at the top of the Power Point window. When the.

IBudget Florida Michael P. Hansen Director Rick Scott Governor Senate Committee on Children, Families, and Elder Affairs November 3, 2011.

Technology and Economic Assessment Panel Progress report 2014 including EUN and CUN report.

What’s in the ReStore project for you? David Martin ESRC National Centre for Research Methods.

IS Analysis and Design. SDLC Systems Development Life Cycle Break problems into management review stages Control cost and time Works best with well understood.

Methyl Bromide Update: Reregistration and Montreal Protocol April 23, 2009 Reddick Fumigants.

TEAP MBTOC Cochairs :  Mohammed Besri  Marta Pizano  Ian Porter CUN Interim Assessments: NON A5 and A5 M o n t r e a l P r o t o c o l O E W G

Page © ASME 2015 Module B – Process B4.Initiating and Terminating Standards Projects Standards and Certification Training.

1 1 TEAP Progress Report vol. 5 TEAP Response to Decision XXV/6 M o n t r e a l P r o t o c o l O E W G m e e t i n g, J u l y ,

Time Remaining 20:00.

1 Joint NDAC/PADAC Meeting January 24, 2005 Determination of “Essential Use” Status of CFC-based Epinephrine MDIs for Nonprescription Treatment of Asthma.

6/22/2016 The Philosophy of Personal Assistance or What its all About Anne Pridmore.

Nominations PEA Meeting October Why ask for Nominations? In a common carriage system gas flows must be approved in advance to keep them within pipeline.

IMPLEMENTATION OF MONTREAL PROTOCOL IN INDIA

MBTOC Critical Use Exemptions 2015

Recommending a Strategy

Recommending a Strategy

Overweight and Obesity: Validation as a Chronic Disease

BIS 221 Education for Service-- snaptutorial.com.

TEAP Progress Report 2011 M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l 1 1.

Recommending a Strategy

TEAP XXV/8 Task Force Report

مدیریت استراتژيک منابع انسانی

M o n t r e a l P r o t o c o l 26th MOP, November , Paris

30 A 30 B 30 C 30 D 30 E 77 TOTALS ORIGINAL COUNT CURRENT COUNT

Medical Technical Options Committee Essential Use Nominations

Learning Quality Support

CFCs in inhalers for asthma and COPD

Communicating Bad News

Recommending a Strategy

Ռազմավարական կառավարում

M E A S U R E ‘G’ P R O G R A M U P D A T E

Recommending a Strategy

Evaluation Report Investigates a problem or a set of options.

Proposer: Debbie Brace Panel Date: 20th March 2014

Communicating Bad News

Recommending a Strategy

Sourcing Issues in outsourcing..

Decision Making.

Resource Adequacy Technical Committee Meeting April 22, 2010

RAASP DSC Change Management Committee update

CCM A3 “P” “D” “C” “A” Date: Title / A3 Theme: Owner: Stakeholders:

Presentation transcript:

Medical Technical Options Committee Essential Use Nominations TEAP Medical Technical Options Committee Essential Use Nominations 1 M o n t r e a l P r o t o c o l M O P - 2 3 , 2 1 - 2 5 N o v e m b e r 2 0 1 1, B a l i 1

Essential Uses: Summary for Metered Dose Inhalers For Parties nominating in 2011: Authorized for 2011; Nominated (Recommended) 2012 and 2013 in metric tonnes Party 2011 Authorized 2012 Nominated (recommended) 2013 Bangladesh 57.0 40.35 (24.67) - China 741.15 562.89 (532.04) Pakistan 39.6 24.1 (24.1) Russian Fed. 212.0 250 (212.0) 125 (0.0) M o n t r e a l P r o t o c o l M O P - 2 3 , 2 1 - 2 5 N o v e m b e r 2 0 1 1, B a l i

Essential Uses MDIs: Bilateral meeting with China, August OEWG Discussions focussed on essentiality of CFCs for MDIs containing anti-cholinergics Locally-made CFC MDIs with anti-cholinergics remain important to China MTOC was not asked to review its assessment of China’s EUN MTOC maintains its original recommendation that CFCs are not essential because more than one alternative is available, and China’s own phase-out strategy is satisfied If needed, China can choose to allocate CFCs to MDIs containing anti-cholinergics within the total allowance approved by Parties. M o n t r e a l P r o t o c o l M O P - 2 3 , 2 1 - 2 5 N o v e m b e r 2 0 1 1, B a l i